Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 37

1.

Gastrointestinal stromal tumors - Summary of mutational status of the primary/secondary KIT/PDGFRA mutations, BRAF mutations and SDH defects.

Kalfusova A, Linke Z, Kalinova M, Krskova L, Hilska I, Szabova J, Vicha A, Kodet R.

Pathol Res Pract. 2019 Dec;215(12):152708. doi: 10.1016/j.prp.2019.152708. Epub 2019 Oct 29.

PMID:
31708372
2.

A systematic review on the genetic analysis of paragangliomas: primarily focused on head and neck paragangliomas.

Guha A, Musil Z, Vicha A, Zelinka T, Pacak K, Astl J, Chovanec M.

Neoplasma. 2019 Jun 29;66(5):671-680. doi: 10.4149/neo_2018_181208N933. Print 2019 Sep.

3.

Improvement of Chemotherapy Solutions Production Procedure in a Hospital Central Chemotherapy Preparation Unit: A Systematic Risk Assessment to Prevent Avoidable Harm in Cancer Patients.

Bourika K, Koutras A, Kalofonos H, Vicha A, Tsiata E, Papadimitriou E, Avgoustakis K, Panagi Z.

Clin Med Insights Oncol. 2019 Jun 10;13:1179554919852933. doi: 10.1177/1179554919852933. eCollection 2019.

4.

Interference of bone marrow CD56+ mesenchymal stromal cells in minimal residual disease investigation of neuroblastoma and other CD45- /CD56+ pediatric malignancies using flow cytometry.

Theodorakos I, Paterakis G, Papadakis V, Vicha A, Topakas G, Jencova P, Karchilaki E, Taparkou A, Tsagarakis NJ, Polychronopoulou S.

Pediatr Blood Cancer. 2019 Aug;66(8):e27799. doi: 10.1002/pbc.27799. Epub 2019 May 7.

PMID:
31066205
5.

Cytometric analysis of cell suspension generated by cavitron ultrasonic surgical aspirator in pediatric brain tumors.

Vaskova M, Tichy M, Zamecnik J, Liby P, Kuzilkova D, Vicha A, Hrabeta J, Kalina T, Stary J, Hrusak O.

J Neurooncol. 2019 May;143(1):15-25. doi: 10.1007/s11060-019-03135-w. Epub 2019 Mar 2.

PMID:
30827009
6.

[Identifying the Importance of MT-3 Expression for Neuroblastoma Cells].

Eckschlager T, Vícha A, Jenčová P, Merlos R, Dostálová S, Buchtelová H, Strmiska V, Michálek P, Heger Z, Adam V.

Klin Onkol. Spring 2018;31(Supplementum1):145-147. Czech.

PMID:
29808689
7.

Heterogeneous MYCN amplification in neuroblastoma: a SIOP Europe Neuroblastoma Study.

Berbegall AP, Bogen D, Pötschger U, Beiske K, Bown N, Combaret V, Defferrari R, Jeison M, Mazzocco K, Varesio L, Vicha A, Ash S, Castel V, Coze C, Ladenstein R, Owens C, Papadakis V, Ruud E, Amann G, Sementa AR, Navarro S, Ambros PF, Noguera R, Ambros IM.

Br J Cancer. 2018 May;118(11):1502-1512. doi: 10.1038/s41416-018-0098-6. Epub 2018 May 14.

8.

Event-free survival of infants and toddlers enrolled in the HR-NBL-1/SIOPEN trial is associated with the level of neuroblastoma mRNAs at diagnosis.

Corrias MV, Parodi S, Tchirkov A, Lammens T, Vicha A, Pasqualini C, Träger C, Yáñez Y, Dallorso S, Varesio L, Luksch R, Laureys G, Valteau-Couanet D, Canete A, Pöetschger U, Ladenstein R, Burchill SA.

Pediatr Blood Cancer. 2018 Jul;65(7):e27052. doi: 10.1002/pbc.27052. Epub 2018 Mar 30.

9.

Comparative gene expression profiling of human metallothionein-3 up-regulation in neuroblastoma cells and its impact on susceptibility to cisplatin.

Merlos Rodrigo MA, Dostalova S, Buchtelova H, Strmiska V, Michalek P, Krizkova S, Vicha A, Jencova P, Eckschlager T, Stiborova M, Heger Z, Adam V.

Oncotarget. 2017 Dec 16;9(4):4427-4439. doi: 10.18632/oncotarget.23333. eCollection 2018 Jan 12.

10.

Molecular pathological predictive diagnostics in a patient with non-small cell lung cancer treated with crizotinib therapy: A case report.

Stanek L, Springer D, Konopasek B, Vocka M, Tesarova P, Syrucek M, Petruzelka L, Vicha A, Musil Z.

Oncol Lett. 2017 Dec;14(6):7545-7548. doi: 10.3892/ol.2017.7167. Epub 2017 Oct 11.

11.

Absence of BRAF mutation in pheochromocytoma and paraganglioma.

Vosecka T, Vicha A, Zelinka T, Jencova P, Pacak K, Duskova J, Benes J, Guha A, Stanek L, Kohoutova M, Musil Z.

Neoplasma. 2017;64(2):278-282. doi: 10.4149/neo_2017_215.

PMID:
28043156
12.

Complete diagnostics and clinical approach for a female patient with unusual glioblastoma: A case study.

Samal F, Stanek L, Filip M, Haninec P, Vícha A, Musil Z, Tesarova P, Petruzelka L, Springer D, Kralickova M, Kohoutova M, Zima T.

Mol Clin Oncol. 2016 Jul;5(1):161-164. Epub 2016 May 10.

13.

[Hepatoblastoma, Etiology, Case Reports].

Puchmajerová A, Křepelová A, Indráková J, Sítková R, Balaščak I, Kruseová J, Švojgr K, Kodet R, Kynčl M, Vícha A, Macek M Jr.

Klin Onkol. 2016;29 Suppl 1:S78-82. Czech.

PMID:
26691946
14.

Fanconi anemia with biallelic FANCD1/BRCA2 mutations - Case report of a family with three affected children.

Svojgr K, Sumerauer D, Puchmajerova A, Vicha A, Hrusak O, Michalova K, Malis J, Smisek P, Kyncl M, Novotna D, Machackova E, Jencik J, Pycha K, Vaculik M, Kodet R, Stary J.

Eur J Med Genet. 2016 Mar;59(3):152-7. doi: 10.1016/j.ejmg.2015.11.013. Epub 2015 Dec 2.

PMID:
26657402
15.

Pacak-Zhuang Syndrome: A New Kid on The Block.

Vicha A, Mercado-Asis LB.

Endocr Pract. 2014 Nov;20(11):1234-5. No abstract available.

PMID:
25492860
16.

Influence of segmental chromosome abnormalities on survival in children over the age of 12 months with unresectable localised peripheral neuroblastic tumours without MYCN amplification.

Defferrari R, Mazzocco K, Ambros IM, Ambros PF, Bedwell C, Beiske K, Bénard J, Berbegall AP, Bown N, Combaret V, Couturier J, Erminio G, Gambini C, Garaventa A, Gross N, Haupt R, Kohler J, Jeison M, Lunec J, Marques B, Martinsson T, Noguera R, Parodi S, Schleiermacher G, Tweddle DA, Valent A, Van Roy N, Vicha A, Villamon E, Tonini GP.

Br J Cancer. 2015 Jan 20;112(2):290-5. doi: 10.1038/bjc.2014.557. Epub 2014 Nov 4.

17.

[Detection of chromosome changes by CGH, array-CGH and SNP array techniques in tumours].

Vosecká T, Musil Z, Vícha A.

Cesk Patol. 2014 Jan;50(1):25-9. Review. Czech.

PMID:
24624983
18.

Neuroblastoma mRNAs predict outcome in children with stage 4 neuroblastoma: a European HR-NBL1/SIOPEN study.

Viprey VF, Gregory WM, Corrias MV, Tchirkov A, Swerts K, Vicha A, Dallorso S, Brock P, Luksch R, Valteau-Couanet D, Papadakis V, Laureys G, Pearson AD, Ladenstein R, Burchill SA.

J Clin Oncol. 2014 Apr 1;32(10):1074-83. doi: 10.1200/JCO.2013.53.3604. Epub 2014 Mar 3.

PMID:
24590653
19.

Current views on cell metabolism in SDHx-related pheochromocytoma and paraganglioma.

Vicha A, Taieb D, Pacak K.

Endocr Relat Cancer. 2014 May 8;21(3):R261-77. doi: 10.1530/ERC-13-0398. Print 2014 Jun. Review.

20.

Changes in MYCN expression in human neuroblastoma cell lines following cisplatin treatment may not be related to MYCN copy numbers.

Prochazka P, Hrabeta J, Vicha A, Cipro S, Stejskalova E, Musil Z, Vodicka P, Eckschlager T.

Oncol Rep. 2013 Jun;29(6):2415-21. doi: 10.3892/or.2013.2383. Epub 2013 Apr 4.

PMID:
23563570
21.

Genetics of pheochromocytoma and paraganglioma syndromes: new advances and future treatment options.

Vicha A, Musil Z, Pacak K.

Curr Opin Endocrinol Diabetes Obes. 2013 Jun;20(3):186-91. doi: 10.1097/MED.0b013e32835fcc45. Review.

22.

[Hereditary pheochromocytoma and paraganglioma].

Musil Z, Vícha A, Zelinka T, Turková H, Labudová T, Kohoutová M, Pacák K.

Klin Onkol. 2012;25 Suppl:S21-6. Czech.

PMID:
22920202
23.

Neuroblastoma stem cells - mechanisms of chemoresistance and histone deacetylase inhibitors.

Khalil MA, Hrabeta J, Cipro S, Stiborova M, Vicha A, Eckschlager T.

Neoplasma. 2012;59(6):737-46. doi: 10.4149/neo_2012_093. Review.

PMID:
22862175
24.

6-mercaptopurine influences TPMT gene transcription in a TPMT gene promoter variable number of tandem repeats-dependent manner.

Kotur N, Stankovic B, Kassela K, Georgitsi M, Vicha A, Leontari I, Dokmanovic L, Janic D, Krstovski N, Klaassen K, Radmilovic M, Stojiljkovic M, Nikcevic G, Simeonidis A, Sivolapenko G, Pavlovic S, Patrinos GP, Zukic B.

Pharmacogenomics. 2012 Feb;13(3):283-95. doi: 10.2217/pgs.11.153.

PMID:
22304581
25.

Molecular cytogenetic characterization in four pediatric pheochromocytomas and paragangliomas.

Vicha A, Holzerova M, Krepelova A, Musil Z, Prochazka P, Sumerauer D, Kodet R, Eckschlager T, Jarosova M.

Pathol Oncol Res. 2011 Dec;17(4):801-8. doi: 10.1007/s12253-011-9385-8. Epub 2011 Apr 5.

PMID:
21461997
26.

A multilocus technique for risk evaluation of patients with neuroblastoma.

Ambros IM, Brunner B, Aigner G, Bedwell C, Beiske K, Bénard J, Bown N, Combaret V, Couturier J, Defferrari R, Gross N, Jeison M, Lunec J, Marques B, Martinsson T, Mazzocco K, Noguera R, Schleiermacher G, Speleman F, Stallings R, Tonini GP, Tweddle DA, Valent A, Vicha A, Roy NV, Villamon E, Ziegler A, Preuner S, Drobics M, Ladenstein R, Amann G, Schuit RJ, Pötschger U, Ambros PF.

Clin Cancer Res. 2011 Feb 15;17(4):792-804. doi: 10.1158/1078-0432.CCR-10-0830.

27.

Paraganglioma in a 13-year-old girl: a novel SDHB gene mutation in the family?

Musil Z, Puchmajerová A, Krepelová A, Vícha A, Panczak A, Veselá J, Widimský J, Turková H, Lisý J, Kohoutová M.

Cancer Genet Cytogenet. 2010 Mar;197(2):189-92. doi: 10.1016/j.cancergencyto.2009.11.010. No abstract available.

PMID:
20193854
28.

Expulsion of amplified MYCN from homogenously staining chromosomal regions in neuroblastoma cell lines after cultivation with cisplatin, doxorubicin, hydroxyurea, and vincristine.

Prochazka P, Hrabeta J, Vícha A, Eckschlager T.

Cancer Genet Cytogenet. 2010 Jan 1;196(1):96-104. doi: 10.1016/j.cancergencyto.2009.08.005.

PMID:
19963143
29.

[Utilization of MLPA to detection of genetic changes in neuroblastoma].

Vícha A, Eckschlager T.

Klin Onkol. 2008;21(4):149-53. Review. Czech.

PMID:
19102220
30.

Expression of glutamate carboxypeptidase II in human brain.

Sácha P, Zámecník J, Barinka C, Hlouchová K, Vícha A, Mlcochová P, Hilgert I, Eckschlager T, Konvalinka J.

Neuroscience. 2007 Feb 23;144(4):1361-72. Epub 2006 Dec 5.

PMID:
17150306
31.

Teratoma in an adolescent with malignant transformation into embryonal rhabdomyosarcoma: case report.

Sumerauer D, Vicha A, Zuntova A, Stejskalova E, Krskova L, Kabickova E, Kodet R, Eckschlager T.

J Pediatr Hematol Oncol. 2006 Oct;28(10):688-92.

PMID:
17023832
32.

Standardisation of operating procedures for the detection of minimal disease by QRT-PCR in children with neuroblastoma: quality assurance on behalf of SIOPEN-R-NET.

Viprey VF, Corrias MV, Kagedal B, Oltra S, Swerts K, Vicha A, Ladenstein R, Burchill SA.

Eur J Cancer. 2007 Jan;43(2):341-50. Epub 2006 Oct 4.

PMID:
17023157
33.

Characterization of drug-resistant neuroblastoma cell lines by comparative genomic hybridization.

Bedrnicek J, Vicha A, Jarosova M, Holzerova M, Cinatl J Jr, Michaelis M, Cinatl J, Eckschlager T.

Neoplasma. 2005;52(5):415-9.

PMID:
16151587
34.

Malignant peripheral primitive neuroectodermal tumor of the kidney.

Vicha A, Stejskalova E, Sumerauer D, Kodet R, Malis J, Kucerova H, Bedrnicek J, Koutecky J, Eckschlager T.

Cancer Genet Cytogenet. 2002 Nov;139(1):67-70.

PMID:
12547163
35.

Detection of minimal bone marrow infiltration in patients with localized and metastatic Ewing sarcoma using RT-PCR.

Sumerauer D, Vícha A, Kucerová H, Kodet R, Housková J, Bedrnícek J, Eckschlager T.

Folia Biol (Praha). 2001;47(6):206-10.

PMID:
11768778
36.

[Detection of minimal residual disease in Ewing's sarcoma using RT-PCR].

Vícha A, Sumerauer D, Eckschlager T, Koutecký J, Kavan P, Smelhaus V, Stanková J, Gajdos P, Stejskalová E.

Cas Lek Cesk. 2000 Nov 8;139(22):685-9. Czech.

PMID:
11191747
37.

Gene aberrations in childhood brain tumors.

Kucerová H, Stejskalová E, Vícha A, Tichý M, Chánová M, Sumerauer D, Koutechký J, Eckschlager T.

Folia Biol (Praha). 2000;46(5):187-90.

PMID:
11055797

Supplemental Content

Support Center